Testing for transfusion-transmissible diseases (TTD) in blood samples

Ended Purchase Order Awarded Last action

Contract number
HT942523P0032
Awardee
Awarding agency
Obligated
$26,368

Award facts

Opportunity
  • HT942523Q0036 Solicitation number
Contract value 26% obligated
  • $26,367.66 Current, with exercised options
  • $102,355.98 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00001 · Screening (TEST/ASSAY/kit) $6,935
Original award $19,433

About this award

The Defense Health Agency awarded a purchase order to Qualtex Laboratories for $102,355.98 on May 27, 2023, for testing blood samples for transfusion-transmissible diseases. Work is performed in Silver Spring, Maryland. The order is firm fixed price with no set-aside designation and an ultimate completion date of May 26, 2026.

Quick answers

Who was awarded contract HT942523P0032?

HT942523P0032 was awarded to Qualtex Laboratories by Defense Health Agency (Department of Defense) on May 27, 2023.

How much is contract HT942523P0032 worth?

The government has obligated $26,368 on HT942523P0032. Its potential value, with all options, is $102,356.

Was contract HT942523P0032 competed?

The extent of competition for HT942523P0032 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award